Marico raises PLIX stake to 84% for ₹1,012 crore

Research Analyst: UJVIN NEVATIA (PROPRIETOR: NEVAT INVESTMENTS) | SEBI Registration No.: INH100009628 Marico Limited (

) has acquired an additional 24.09% stake in Satiya Nutraceuticals for ₹1,012.03 crore, taking its ownership to 84.09% on a fully diluted basis. Satiya owns the PLIX health and wellness brand. What happened? The acquisition was completed on October 5, 2026 through a cash transaction with Satiya's founders and certain other shareholders. Marico had earlier acquired 60% of Satiya. The company's consolidated turnover increased to ₹864.31 crore in FY26 from ₹432.84 crore in FY25. Marico plans to acquire the remaining 14.09% stake in July 2027, subject to the agreed terms. The base consideration for that tranche can be up to ₹592 crore plus additional consideration linked to milestones. Why does it matter? The transaction increases Marico's exposure to value-added foods, nutrition, personal care and wellness. It also gives Marico greater economic ownership of a business that has more than doubled its turnover in FY26. My view The revenue growth makes the business attractive, but the ₹1,012 crore investment needs to be assessed against the earnings and cash flows that Satiya can generate. Marico is moving towards full ownership, so future value creation will depend on scaling PLIX while maintaining margins and controlling customer acquisition and distribution costs. What I am watching next I would track PLIX revenue growth, profitability and cash generation after consolidation. I would also watch the terms and consideration for the remaining 14.09% stake in July 2027 and whether the business delivers returns that justify the capital deployed. No Recommendations Source: NDTV Profit Disclosure: I, my entity, associates or relatives do not have any holding, position or other material interest in Marico Limited.